GlobeNewswire

Akin Gump Adopts FileTrail for Information Governance Program

Share

Leading international law firm to use FileTrail GPS to manage records retention, apply client requirements across information repositories

SAN JOSE, Calif., June 04, 2019 (GLOBE NEWSWIRE) -- FileTrail today announced that Akin Gump Strauss Hauer & Feld LLP, a leading international law firm with more than 900 lawyers globally, has adopted FileTrail GPS to support its information governance program. Akin Gump will use FileTrail to control information across the firm's data repositories in line with its information governance policies, as well as its clients’ outside counsel guidelines.

“Law firms today face tough scrutiny from clients when it comes to security and information management. Firms that can demonstrate their commitment to protecting their clients' information inspire confidence and trust," said Darrell Mervau, CEO, FileTrail. “The IG team at Akin Gump is taking a comprehensive and methodical approach that addresses the policy, process, technology and cultural aspects of successful information governance.”

“In a digital environment, information is saved in so many different places, it is no longer practical or efficient to rely on individuals to manually track document classification, retention and disposition,” said Christopher Egan, Assistant General Counsel for Information Governance at Akin Gump. “FileTrail is a core part of our vision to automate controls on records retention and monitor compliance with firm policies and client requirements on an ongoing basis. We value the FileTrail approach in providing visibility across multiple systems, as well as the responsiveness and support of its development team.”

FileTrail GPS will enable authorized users to view documents stored in Akin Gump’s document management system, as well as file shares and e-discovery archives. The firm will store policies approved by the Office of the General Counsel in FileTrail and apply them to relevant information assets. In addition, Akin Gump is integrating FileTrail with other business systems to enforce client-specific retention and disposition requirements — from the inception of a new matter to the appropriate period of time after it closes.

Managing the Information Lifecycle
Actively managing the information lifecycle is essential to law firm risk management, as well as client service delivery. When documents are received or created by the firm, FileTrail GPS automatically applies the correct policies to each item according to pre-defined rules. Once retention periods have expired, FileTrail triggers workflows for the review, approval and disposition of specific records. FileTrail also automatically captures an audit trail of all activity and decisions related to client matter files.

InOutsource, a consulting firm with in-depth expertise in law firm information management, is working with Akin Gump on its FileTrail implementation, as well as data mapping and data cleansing.

About Akin Gump
Akin Gump Strauss Hauer & Feld LLP is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.

About FileTrail
FileTrail is reshaping the information risk management landscape, enabling firms to meet urgent client demands, pass audits and address new compliance rules with a modern approach to records management and information governance. FileTrail centralizes, simplifies and automates the IG life cycle, including policy management, document review and disposition — integrating across physical records and electronic repositories — so firms can address OCGs, lateral intake, matter mobility and client audit response. It’s time to move beyond records management, and FileTrail is leading the way. For more information about FileTrail’s records management and information governance software, visit www.filetrail.com.           

Media Contact
Vicki LaBrosse
Edge Legal Marketing for FileTrail
vlabrosse@edgelegalmarketing.com
651.552.7753

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Inventiva secures new patent in the US strengthening the protection of its lead product candidate lanifibranor20.8.2019 17:45:00 CESTPress release

Inventiva secures new patent in the US strengthening the protection of its lead product candidate lanifibranor New patent granted in the United States by the USPTO protects the use of lanifibranor for the treatment of fibrotic diseases until June 2035 This patent strengthens the protection of lanifibranor in the United States Daix (France), August 20, 2019 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas of fibrosis, lysosomal storage disorders and oncology, today announced that the United States Patent and Trademark Office (USPTO) granted a new patent on August 20, 2019 that protects the use of lanifibranor for the treatment of fibrotic diseases until June 2035. This new patent further strenghens Inventiva’s patent portfolio for lanifibranor, the Company’s lead product candidate, in the United States, which already comprised a New Chemical Entity (NCE) patent and a patent protect

PCI Biotech: Invitation to second quarter and first half 2019 results presentation20.8.2019 15:38:00 CESTPress release

Oslo, Norway, 20 August 2019 - PCI Biotech invites to a presentation of the company's second quarter and first half 2019 results on Wednesday 28 August 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday 28 August, 08:30am – 09:30am CEST (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo. The presentation will be held in English and if you wish to attend the presentation, please confirm with an e-mail to post@pcibiotech.com. The presentation will also be a live webcast and can be accessed through www.pcibiotech.com. It will be possible to post questions through the webcast console. The interim report and the presentation will be available on www.newsweb.no and on the company's webpage, www.pcibiotech.com from 07:00am (CEST) on 28 August 2019. For further information, please contact: Ronny Skuggedal, CFO Email: rs@pcibiotech.no Mobile: +47 9400 5757 About PCI Biotech PCI Biotech is a biopharmaceutica

Regarding resignation of member of the Supervisory Board20.8.2019 15:30:00 CESTPress release

We hereby inform that, T. Lukoševičius, a member of Supervisory Board of AB Klaipedos nafta (hereinafter – the Company) 20 August 2019 submitted a notice of resignation of members of Supervisory Board of the Company as of 3 September 2019 (this day is the last day of the mandate). It should be noted that, currently the Supervisory Board of the Company consists of 3 members, 2 of them are independent. After the resignation of T. Lukoševičius, the Ministry of Energy of the Republic of Lithuania will conduct the selection of new member of the Supervisory Board. The Supervisory Board is elected by the General Meeting of Shareholders for 4 years. If individual members of the Supervisory Board are elected, they shall be elected only until the end of the term of office of the current Supervisory Board. Jonas Lenkšas, Chief Financial Officer,+370 694 80594

SERSTECH AB: Boardmember Anna Werntoft resigns from the Board of Serstech20.8.2019 13:40:00 CESTPress release

Anna Werntoft will leave the board of directors effective on the 30th of September. The reason for her resignation is that she enters a new operational position with terms that does not allow external assignments. Serstech wishes Anna all the best in her new position and would like to thank her for her contribution while being on the Serstech Board. The Serstech will consist of three Board members until the vacant position is filled. The search for a replacement has started and will be concluded before the next annual general meeting. For further information, please contact: Stefan Sandor, CEO, Serstech AB tel: +46 739 606067 email: ss@serstech.com Thomas Pileby, Chairman of the Board, Serstech AB tel: +46 702 072643 email: tp@serstech.com Company website: www.serstech.com The information was submitted for publication, through the agency of the contact person set out above at 13:40 CET on August 20, 2019. Certified advisor to Serstech is Västra Hamnen Corporate Finance AB, phone: 040-2